Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Eckstein

Showing results (181-190 of 263) with videos related to

Pageof 27
Sort By:
Histopathology|July 27, 2019
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinomaVeronika Weyerer, Rebecca Weisser, Evgeny A Moskalev, et al.
Scientific Reports|February 21, 2023
Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progressionMiriam Saponaro, Sina Flottmann, Markus Eckstein, et al.
Scientific Reports|January 2, 2023
CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progressionMiriam Saponaro, Sina Flottmann, Markus Eckstein, et al.
Gastroenterology|June 17, 2026
TIM3 signaling in effector T cells acts as an immunometabolic switch in the purine degradation pathway to suppress intestinal inflammationAnnkathrin Knauss, Michael Gabel, Cora Kaufmann, et al.
Autophagy|March 28, 2022
Acute systemic knockdown of <i>Atg7</i> is lethal and causes pancreatic destruction in shRNA transgenic miceLaura Mainz, Mohamed A F E Sarhan, Sabine Roth, et al.
Nature Medicine|January 9, 2023
Multistain deep learning for prediction of prognosis and therapy response in colorectal cancerSebastian Foersch, Christina Glasner, Ann-Christin Woerl, et al.
Oncology|October 20, 2021
A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early ResultsAxel Wein, Robert Stoehr, Stephan Kersting, et al.
Cell Death & Disease|November 28, 2019
DAPK1 loss triggers tumor invasion in colorectal tumor cellsSara Steinmann, Philipp Kunze, Chuanpit Hampel, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 21, 2023
Transrectal Absorber Guide Raster-Scanning Optoacoustic Mesoscopy for Label-Free In Vivo Assessment of ColitisAdrian Buehler, Emma Brown, Lars-Philip Paulus, et al.
Cellular and Molecular Life Sciences : CMLS|September 22, 2023
Loss of ORP3 induces aneuploidy and promotes bladder cancer cell invasion through deregulated microtubule and actin dynamicsXue Wang, Junnan Liu, Anca Azoitei, et al.
Pageof 27

Showing results (181-190 of 263) with videos related to

Sort By:
Pageof 27
Histopathology|July 27, 2019
Distinct genetic alterations and luminal molecular subtype in nested variant of urothelial carcinomaVeronika Weyerer, Rebecca Weisser, Evgeny A Moskalev, et al.
Scientific Reports|February 21, 2023
Author Correction: CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progressionMiriam Saponaro, Sina Flottmann, Markus Eckstein, et al.
Scientific Reports|January 2, 2023
CDCP1 expression is frequently increased in aggressive urothelial carcinoma and promotes urothelial tumor progressionMiriam Saponaro, Sina Flottmann, Markus Eckstein, et al.
Gastroenterology|June 17, 2026
TIM3 signaling in effector T cells acts as an immunometabolic switch in the purine degradation pathway to suppress intestinal inflammationAnnkathrin Knauss, Michael Gabel, Cora Kaufmann, et al.
Autophagy|March 28, 2022
Acute systemic knockdown of <i>Atg7</i> is lethal and causes pancreatic destruction in shRNA transgenic miceLaura Mainz, Mohamed A F E Sarhan, Sabine Roth, et al.
Nature Medicine|January 9, 2023
Multistain deep learning for prediction of prognosis and therapy response in colorectal cancerSebastian Foersch, Christina Glasner, Ann-Christin Woerl, et al.
Oncology|October 20, 2021
A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early ResultsAxel Wein, Robert Stoehr, Stephan Kersting, et al.
Cell Death & Disease|November 28, 2019
DAPK1 loss triggers tumor invasion in colorectal tumor cellsSara Steinmann, Philipp Kunze, Chuanpit Hampel, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|April 21, 2023
Transrectal Absorber Guide Raster-Scanning Optoacoustic Mesoscopy for Label-Free In Vivo Assessment of ColitisAdrian Buehler, Emma Brown, Lars-Philip Paulus, et al.
Cellular and Molecular Life Sciences : CMLS|September 22, 2023
Loss of ORP3 induces aneuploidy and promotes bladder cancer cell invasion through deregulated microtubule and actin dynamicsXue Wang, Junnan Liu, Anca Azoitei, et al.
Pageof 27